drugset / Trial / NCT06361212

Ethoximod Pharmacokinetics In Healthy Subjects

NCT06361212 ↗

Phase 1 Completed 65 enrolled Longevity Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of this clinical trial is to evaluate the tolerability, pharmacokinetics and pharmacodynamics of Ethoximod in healthy subjects. The main questions it arms to answer are: 1. to evaluate the safety and tolerance of Ethoximod in healthy subjects after single or repeated doses. 2. to assess the pharmacokinetics and pharmacodynamics of Ethoximod in healthy subjects after single or repeated doses. 3. to evaluate of the effect of food on the pharmacokinetics of Ethoximod in healthy subjects Participants will receive test tablets or placebo at the indicated date and collect blood samples.

Timeline

Start
2022-09-01
Primary completion
2022-09-20
Completion
2024-01-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ethoximod Unknown 5 mg —
Subject Ethoximod Unknown 10 mg —

Indications